Clinical Decision Support Systems Market Size | Report by 2027

The Clinical Decision Support Systems in healthcare market was valued at US$ 2,772.60 million in 2018 and it is projected to reach US$ 5,983.38 million by 2027; it is expected to grow at a CAGR of 9.2% from 2019 to 2027.

Clinical decision support systems (CDSS) are computer-based programs that are used to analyze the patient data in order to assist the hospitals, clinics, and ambulatory care centers. CDSS analyses the data from EHRs to assist the physicians by providing the prompts and reminders about the patients and their medication. The growth of the Clinical Decision Support Systems in healthcare market is attributed to the rising pressure on healthcare institutions to provide quality health at reduced costs, rising prevalence of chronic diseases, growing adoption of big data & health IT tools, number of initiatives taken by governments, rising developments in the fields of healthcare IT, rising number of hospitals. However, the growth of the market is restrained by factors such as the concerns regarding data privacy.

The Clinical Decision Support Systems in healthcare market is expected to witness substantial growth post-pandemic. The Clinical Decision Support Systems in healthcare market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Lucrative Regions for Clinical Decision Support Systems in Healthcare Market

Get more information on this report : Request Free Sample PDF

Market Insights

Growing Applications of Clinical Decision Support Systems in Healthcare to Drive Clinical Decision Support Systems in Healthcare Market Growth

Healthcare providers face various challenges in the industry that impacts the performance of these companies and become hindered by the administrative element of the profession. In an industry that is as competitive as healthcare, the main aim of the business is to find out ways and solutions to reduce expenses for the operational and functional costs due to increasing government pressure regarding the elevating prices of healthcare drugs and devices. The adoption of a value-based care system is also one of the major reasons. The healthcare industry is in a constant pressure to reduce healthcare delivery costs and thus have to implement methods that help to enhance health plans, evidence-based patient care, manage regulations, and consolidate healthcare systems simultaneously. The rising price pressure and patent cliffs compel healthcare providers to cut on drug prices, encourage the use of generics instead of branded and scale back the reimbursement. This, in turn, is gradually reducing the profit margins and annual net sales of the healthcare providers that lead to the immediate requirement of a strategic plan to cut down on the operational costs.

Healthcare IT system helps in reducing the costs associated with chronic diseases, by helping the healthcare provider to keep a real-time track of patient’s health status. As per the American Diabetes Association, the estimated costs of diagnosed diabetes rose to $327 billion in 2017, including $237 billion in direct medical costs and $90 billion in reduced productivity. This cost can be managed efficiently by including a clinical decision support system that to help manage diabetes, keep track of individual dosage pattern which can help patients get assistance with disease and medication management and overcome the disease.

The clinical decision support systems have been witnessing rapid acceptance by healthcare providers as well as patients during recent years, owing to the benefits being offered by it. In support, there have been various significant collaborations and partnerships in the market, which have fuelled the growth of the clinical decision support systems market. The market has been marked mainly by the presence of big and small players; however, during recent years, large companies have begun to take an interest in this space.

Community Preventive Services Task Force (CPSTF) is a nonfederal, independent public health panel. CPSTF experts come from a variety of fields such as practice, research, and policy expertise in community services. CPSTF was established in 1996 by the US Department of Health and Human Services. Research conducted by CPSTF validated that the CDSS is an effective tool in healthcare practice, and it can be replicated for positive results.

According to the reports published by Mercom Capital Group, the global digital health VC funding has reached to USD 7.2 billion, increased by 42%, the CDSS received USD 514 million. This funding has boosted the global CDSS companies and medical research startups where they can invest in new innovative solutions. Advancements in the CDSS system will help healthcare providers to provide better care and treatment to their patients. 

For instance, in September 2017, Mayo Clinic has developed a CDS tool, “CareSelect Lab” in collaboration with the National Decision Support Company (NDSC). CareSelect Lab provides the comprising recommendations for lab test order. CareSelece Lab enables to deliver of EHR-integrated guidelines with the more than 1,500 best-practice care models—maintained by Mayo Clinic. Epic Systems partnered with Mayo Clinic in September 2017. Together they have launched “Ask Mayo Clinic.” It offers a web-based symptom assessment system by leveraging the capability of “Epic MyChart.” It assists patients in managing their care. Such kind of collaborations provide potential opportunities for CDSS players to grow in future.

Chronic diseases, including heart disease, stroke, diabetes, and obesity, are the leading causes of death in the world and account for most of the nation’s health care costs. According to the report of CDC, in 2018, approximately more than 9% of the population has diabetes, which is the leading cause of kidney failure, lower-limb amputations in the US. Moreover, the data also suggests that 1.5 million Americans are diagnosed with diabetes every year in the US. Similar trends for the high presence of diabetes are prevalent around other geographies of the globe that include Asia Pacific, Europe, the Middle East, and Africa. For instance, according to IDF Diabetes Atlas published by the International Diabetes Federation in 2017, south-east Asia is home to approximately one-fifth (19%) of the total diabetes population worldwide.

According to the report of American College of Cardiology Foundation, in 2018, Coronary heart disease (CHD) was the leading cause of deaths attributable to cardiovascular disease (CVD) in the US, which is followed by stroke (16.8%), high BP (9.4%), heart failure (HF) (9.0%), and other CVDs (17.9%). By 2035, approximately 130 million adults in the US population are projected to have some form of CVD. Thus, increasing the geriatric population and related chronic diseases are expected to drive the adoption of clinical decision support systems, which will further drive the growth of the global clinical decision support systems market over the forecast years.

The obesity rates have been increasing rapidly in developed as well as developing economies across the globe. Factors such as sedentary life and an unhealthy lifestyle are considered to be the major factors for the rise in the number of obese individuals. As per data published by The Organisation for Economic Co-operation (OECD), in 2015, around 19.5% of the adult population was obese. This rate ranges from less than 6% in Korea and Japan to more than 30% in

Hungary, New Zealand, Mexico, and the United States. The prevalence has increased rapidly in Australia, Canada, Chile, South Africa, and the United Kingdom in the recent decade. Obesity levels are anticipated to be high in the United States, Mexico, and England, consisting of around 47%, 39%, and 35% of the population, respectively, by the end of 2030.

Diabetes is a life-threatening disease with no specialized cure. It is mainly caused by the body’s inability to produce or effectively utilize the hormone insulin. This inability prevents the body from adequately regulating blood glucose levels. Diabetes is one of the largest global health emergencies of the 21st century. Each year more and more people live with this condition, which can result in life-changing complications. According to the International Diabetes Federation (IDF), in 2017, the number of people with diabetes in North America was approximately 46 million, which is expected to grow at 62 million in 2045. Hence, the rise in the prevalence of chronic diseases is anticipated to drive the market for clinical decision support systems during the forecast period.

Component-Based Insights

In terms of component, the Clinical Decision Support Systems in healthcare market is segmented into software, hardware, and services. In 2019, the software solution segment held larger share of the market. Also, the same segment is estimated to register highest CAGR during the forecast period.

Clinical Decision Support Systems in Healthcare Market, by Component – 2019 and 2027

Get more information on this report : Request Free Sample PDF

Delivery Mode-Based Insights

In terms of delivery mode, the Clinical Decision Support Systems in healthcare market is segmented into on premise, cloud based, web based. In 2018, the on premise segment held the largest share of the market, by delivery mode.

Application-Based Insights

Based on application, the Clinical Decision Support Systems in healthcare market is segmented into drug interaction, drug allergy alerts, clinical reminders, clinical guidelines and others. In 2018, the drug allergy alerts segment held the largest share of the market, by application. However, the clinical reminders segment is also expected to grow at the fastest rate during the coming years.

End User-Based Insights

In terms of end user, the Clinical Decision Support Systems in healthcare market is segmented into hospitals, ambulatory care centers, diagnostic labs. In 2018, the hospitals segment held the largest share of the market, by end user. In addition, the hospitals segment is also expected to grow at the fastest rate during the coming years owing majority of adoption by hospitals.

Strategic Insights

The Clinical Decision Support Systems in healthcare market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

Clinical Decision Support Systems in Healthcare Market – by Component

• Software

o MedMined Softwar

o ICNet Software

o Sentri7 Software

o TheraDoc Software

o Purell Smartlink Software

o Others

• Hardware
• Services

o Implementation Services

o Support and Maintenance Services

• o Training and Consulting Services

Clinical Decision Support Systems in Healthcare Market – by Delivery Mode

• On Premise
• Cloud-Based
• Web Based

Clinical Decision Support Systems in Healthcare Market – by Application

• Drug-drug Interaction
• Drug Allergy
• Clinical Reminders 
• Clinical Guidelines
• Others

Clinical Decision Support Systems in Healthcare Market – by End User

• Hospitals
• Ambulatory Care Centers
• Diagnostic Labs

Clinical Decision Support Systems in Healthcare Market – by Geography

• North America

  • US
  • Canada
  • Mexico

• Europe

  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe

• Asia Pacific (APAC)

  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of APAC

• Middle East & Africa (MEA)

  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA

• South America and Central America (SCAM)

  • Brazil
  • Argentina
  • Rest of SCAM

Company Profiles

• Cerner Corporation,
• Medical Information Technology, Inc.
• BD
• Wolters Kluwer N.V.
• Baxter International Inc.
• Premier
• Koninklijke Philips N.V.
• RELX (Elseiver)
• PeraHealth
• Epic Systems Corporation